Literature DB >> 9811350

Increased immunostaining of fibulin-1, an estrogen-regulated protein in the stroma of human ovarian epithelial tumors.

P Roger1, P Pujol, A Lucas, P Baldet, H Rochefort.   

Abstract

Fibulin-1, an extracellular matrix protein, is secreted by human ovarian metastatic cancer cell lines under estrogen stimulation. Fibulin-1 expression was quantified by immunohistochemistry and computer-aided image analysis in 44 human ovarian epithelial tumors and 14 normal ovaries. The fibulin-1 staining intensity in proximal stroma, close to the surface of epithelial cells and tumor cells, progressively increased from normal ovaries to serous carcinomas. In all lesions, excluding cystadenomas, fibulin-1 accumulation was higher in proximal stroma than in distant stroma. In situ hybridization demonstrated strong fibulin-1 gene expression in epithelial cells of serous ovarian carcinomas and some cysts. The weak expression of fibulin-1 RNA in some stromal cells of these tumors could not explain the strong fibulin-1 protein accumulation in tumor stroma, which was therefore mostly produced by tumor epithelial cells. In carcinomas, fibulin-1 staining was not correlated with the percentage of estrogen receptor-alpha (ERalpha)-stained nuclei but was inversely correlated with the progesterone receptor. However, in cystadenomas and borderline tumors, both fibulin-1 and ERalpha protein levels increased, in comparison with normal ovaries, suggesting an effect of estrogens in the early steps of tumorigenesis. This fibulin-1 overexpression, demonstrated in vivo in ovarian carcinomas, might be a useful indicator for predicting cancer risk and/or aggressiveness.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811350      PMCID: PMC1853396          DOI: 10.1016/S0002-9440(10)65746-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Ovarian cancer--unrealistic expectations.

Authors:  C O Granai
Journal:  N Engl J Med       Date:  1992-07-16       Impact factor: 91.245

2.  Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells.

Authors:  V Cavailles; M Garcia; H Rochefort
Journal:  Mol Endocrinol       Date:  1989-03

Review 3.  Endocrine factors in common epithelial ovarian cancer.

Authors:  B R Rao; B J Slotman
Journal:  Endocr Rev       Date:  1991-02       Impact factor: 19.871

4.  Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.

Authors:  K R Geisinger; T E Kute; M J Pettenati; C E Welander; Y Dennard; L A Collins; M E Berens
Journal:  Cancer       Date:  1989-01-15       Impact factor: 6.860

5.  Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival.

Authors:  J Isola; O P Kallioniemi; J M Korte; T Wahlström; R Aine; M Helle; H Helin
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

6.  Estrogen and progesterone receptors in ovarian cancer.

Authors:  M Harding; S Cowan; D Hole; L Cassidy; H Kitchener; J Davis; R Leake
Journal:  Cancer       Date:  1990-02-01       Impact factor: 6.860

7.  Immunostaining of cathepsin D in breast cancer: quantification by computerised image analysis and correlation with cytosolic assay.

Authors:  T Maudelonde; J P Brouillet; P Roger; V Giraudier; A Pages; H Rochefort
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

8.  Steroid receptors in ovarian carcinoma: immunohistochemical determination may lead to new aspects.

Authors:  F Kommoss; J Pfisterer; M Thome; W Schäfer; W Sauerbrei; A Pfleiderer
Journal:  Gynecol Oncol       Date:  1992-12       Impact factor: 5.482

9.  Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1.

Authors:  F Galtier-Dereure; F Capony; T Maudelonde; H Rochefort
Journal:  J Clin Endocrinol Metab       Date:  1992-12       Impact factor: 5.958

10.  Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure.

Authors:  W S Argraves; H Tran; W H Burgess; K Dickerson
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

View more
  12 in total

1.  Structural and functional characterization of the human and mouse fibulin-1 gene promoters: role of Sp1 and Sp3.

Authors:  Mirco Castoldi; Mon-Li Chu
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

2.  Research Resource: STR DNA profile and gene expression comparisons of human BG-1 cells and a BG-1/MCF-7 clonal variant.

Authors:  Yin Li; Yukitomo Arao; Julie M Hall; Sandra Burkett; Liwen Liu; Kevin Gerrish; Vincent Cavailles; Kenneth S Korach
Journal:  Mol Endocrinol       Date:  2014-12

3.  Loss of fibulin-2 expression is associated with breast cancer progression.

Authors:  Chun-Hui Yi; David J Smith; William W West; Michael A Hollingsworth
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 4.  Hormone response in ovarian cancer: time to reconsider as a clinical target?

Authors:  Francesmary Modugno; Robin Laskey; Ashlee L Smith; Courtney L Andersen; Paul Haluska; Steffi Oesterreich
Journal:  Endocr Relat Cancer       Date:  2012-11-09       Impact factor: 5.678

5.  Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.

Authors:  Mikhail G Dozmorov; Joseph T Azzarello; Jonathan D Wren; Kar-Ming Fung; Qing Yang; Jeffrey S Davis; Robert E Hurst; Daniel J Culkin; Trevor M Penning; Hsueh-Kung Lin
Journal:  BMC Cancer       Date:  2010-12-06       Impact factor: 4.430

6.  Identification of stromal proteins overexpressed in nodular sclerosis Hodgkin lymphoma.

Authors:  Laurence de Leval; Vincent Castronovo; Philippe Kischel; David Waltregny; Yannick Greffe; Gabriel Mazzucchelli; Edwin De Pauw
Journal:  Proteome Sci       Date:  2011-10-05       Impact factor: 2.480

Review 7.  The role of the tumor stroma in ovarian cancer.

Authors:  Ben Davidson; Claes G Trope; Reuven Reich
Journal:  Front Oncol       Date:  2014-05-13       Impact factor: 6.244

8.  A preliminary quantitative proteomic analysis of glioblastoma pseudoprogression.

Authors:  Peng Zhang; Zhengguang Guo; Yang Zhang; Zhixian Gao; Nan Ji; Danqi Wang; Lili Zou; Wei Sun; Liwei Zhang
Journal:  Proteome Sci       Date:  2015-03-12       Impact factor: 2.480

9.  The highly prolific phenotype of Lacaune sheep is associated with an ectopic expression of the B4GALNT2 gene within the ovary.

Authors:  Laurence Drouilhet; Camille Mansanet; Julien Sarry; Kamila Tabet; Philippe Bardou; Florent Woloszyn; Jérome Lluch; Grégoire Harichaux; Catherine Viguié; Danielle Monniaux; Loys Bodin; Philippe Mulsant; Stéphane Fabre
Journal:  PLoS Genet       Date:  2013-09-26       Impact factor: 5.917

10.  Elevated expression and altered processing of fibulin-1 protein in human breast cancer.

Authors:  L M Greene; W O Twal; M J Duffy; E W McDermott; A D Hill; N J O'Higgins; A H McCann; P A Dervan; W S Argraves; W M Gallagher
Journal:  Br J Cancer       Date:  2003-03-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.